FDA approves Biaxin for MAC prophylaxis. Food and Drug Administration.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D017291:Clarithromycin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D014486:United States Food and Drug Administration
D010919:Placebos; D017291:Clarithromycin